Wednesday, November 25, 2009, 12:39am EST - Canadian Markets open in 8 hours and 51 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Clarient, Inc. (CLRT)

 On Nov 24: 2.40 USD  Down 0.08 (3.23%)  
MORE ON CLRT
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Clarient, Inc. (NCM:CLRT) Delayed quote dataEdit
After Hours: 2.40 Down 0.00 (0.02%) as of 4:15pm EST on 11/24/09
Last Trade: 2.40 USD
Trade Time: Nov 24
Change: Down 0.08 (3.23%)
Prev Close: 2.48
Open: 2.46
Bid: 2.36 x 100
Ask: 2.93 x 100
1y Target Est: 4.25
Day's Range: 2.34 - 2.48
52wk Range: 1.00 - 4.43
Volume: 342,254
Avg Vol (3m): 823,400
Market Cap: 188.23M
P/E (ttm): N/A
EPS (ttm): -0.11
Div & Yield: N/A (N/A%)
Clarient, Inc. (CLRT)
1d  5d  3m  6m  1y  2y  5y  max 
 Add CLRT to Portfolio   Download Data

HEADLINES
• 4-Star Stocks on the Upswing
at Motley Fool (Tue 2:36pm)
• CLARIENT, INC Financials
EDGAR Online Financials (Thu, Nov 19)
• CLARIENT, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
EDGAR Online (Tue, Nov 17)
• Clarient, Inc.: Warming Up or Cooling Off?
at Motley Fool (Mon, Nov 16)
• CLARIENT, INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Nov 13)
• Clarient to Present at Upcoming Healthcare Investor Conferences in New York City
PRNewswire (Mon, Nov 9)
• Cardiac Science Appoints Healthcare Executive Ronald A. Andrews, Jr. to Board of Directors
PRNewswire (Thu, Nov 5)
• Ambac, Mod-Pac: Midday Volume Plays
at TheStreet.com (Wed, Nov 4)
• HEADLINE STOCKS-U.S. small/midcap stocks on the move on Nov 4
at Reuters (Wed, Nov 4)
• New Star Analyst Rankings for Clarient, Inc.
StarMine (Wed, Nov 4)
More Headlines for CLRT...
ANALYST
EPS Est (next year) (Dec-07) : N/A
EPS Est (in 2 years) (Dec-08) : N/A
Avg Rec (current)*: 1.7
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Clarient, Inc. operates as an oncology diagnostics services company in the United States. It provides cellular assessment and cancer characterization to community pathologists, academic researchers and university hospitals, and bio pharmaceutical ...

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices